Vaxcyte (PCVX)

• Market cap: $5.79B
• 1 day: 0%
• 5 days: 5.24%
• 1 month: 28.63%
• 3 months: 24.25%
• 6 months: 35.47%
• Year to date: -46.49%
• 1 year: -60.49%
• 5 years: 17.6%
• 10 years: 70.44%
• Sector: Healthcare
• Industry: Biotechnology

About: Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Employees: 414